Medical Device Network on MSN
JPM26: Intuitive’s stock falls despite positive FY25 financials
Intuitive reported preliminary FY25 revenues of around $10.06bn, reflecting a 21% increase on $8.35bn in FY24.
Should you buy stock in Intuitive Surgical right now? Before you buy stock in Intuitive Surgical, consider this: The Motley ...
The acquisition aligns with the Intuitive Machines vision, strengthening the Company’s position as a vertically integrated ...
At the 2026 JP Morgan Healthcare event, Intuitive Surgical outlined how its robotic surgical systems continued to grow ...
Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.
Intuitive Machines' acquisition of Lanteris and KinetX positions it as a vertically integrated satellite provider. Read why ...
Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew ...
With no fresh headline catalyst, Intuitive Surgical (ISRG) is drawing attention for its recent share performance as investors ...
Intuitive Machines shares are trading higher Monday. Clear Street maintained a Buy rating and raised the price target to $25.
Deutsche Bank downgraded Intuitive Surgical, Inc. due to rising competition from cheaper alternatives and some instruments being remanufactured. For now, da Vinci remains the go-to choice for surgeons ...
IM's CEO said the acquisition could secure some choice contracts for Intuitive Machines in space and defense.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results